Monday, February 27, 2023
7:00 PM – 9:00 PM ET
Please note this live virtual meeting is at 7:00 PM Eastern; 6:00 PM Central; 5:00 PM Mountain; 4:00 PM Pacific
FACULTY
 |
Amitkumar N. Mehta, MD Director, Lymphoma Program, and IEC/CAR-T Program & Medical Director, Clinical Trial Office, Associate Professor Birmingham, Alabama |
 |
Mayur Narkhede, MD Assistant Professor at UAB Medicine, Division of Hematology/Oncology Birmingham, Alabama |
PROGRAM DESCRIPTION
This virtual summit meeting activity is designed for oncologists, hematologists, nurse practitioners, pharmacists, and other members of the multi-disciplinary oncology care team with the goal of increasing their: recognition of the role of bispecific antibodies in management of lymphoma, as well as clinical trial opportunities for patients with B-cell lymphomas; confidence discussing clinical trial outcomes with bispecific antibodies in lymphoma; awareness of specific adverse events associated with anti-CD20 therapies; and their recognition of multidisciplinary best practices for management of adverse events with targeted therapies for lymphoma.
TARGET AUDIENCE
This activity is designed to meet the educational needs of medical oncologists, hematologists, nurse practitioners, pharmacists, and other members of the multi-disciplinary oncology care team.
LEARNING OBJECTIVES
- Evaluate the need for novel bispecific antibodies and combinations in B-cell lymphoma management
- Assess clinical outcomes from key trials of therapies for B-cell NHLs, including bispecific antibodies in development
- Recognize the potential adverse events associated with bispecific antibody therapies and best practices for multidisciplinary management
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 2.0 ANCC contact hours.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 2.0 contact hours of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]
